These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6404001)

  • 1. Enteric-coated aspirin and cyclooxygenase inhibition.
    Svensson J; Mettinger KL; Blombäck M
    Thromb Res; 1983 Jan; 29(1):99-102. PubMed ID: 6404001
    [No Abstract]   [Full Text] [Related]  

  • 2. Enteric-coated aspirin, platelet cyclooxygenase activity and function.
    Rao GH; Radh E; Johnson GJ; White JG
    Prostaglandins Leukot Med; 1984 Mar; 13(3):341-7. PubMed ID: 6425869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase.
    Jakubowski JA; Stampfer MJ; Vaillancourt R; Faigel D; Deykin D
    J Lab Clin Med; 1986 Dec; 108(6):616-21. PubMed ID: 3097223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative antiplatelet effect of low-dose enteric coated aspirin.
    Jakubowski JA; Stampfer MJ; Vaillancourt R; Deykin D
    Br J Haematol; 1985 Aug; 60(4):635-42. PubMed ID: 3927970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
    Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
    Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.
    Patrignani P; Panara MR; Greco A; Fusco O; Natoli C; Iacobelli S; Cipollone F; Ganci A; Créminon C; Maclouf J
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():129-31. PubMed ID: 7732817
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin In The Prevention Of Pre-Eclampsia: Where Are We Now?
    Khalid A; Byrne BM
    Ir Med J; 2018 Mar; 111(3):704. PubMed ID: 30376222
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of platelet prostaglandin synthetase by oral aspirin.
    Burch JW; Stanford N; Majerus PW
    J Clin Invest; 1978 Feb; 61(2):314-9. PubMed ID: 413839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of hepatic and extrahepatic metabolism of aspirin in selective inhibition of platelet cyclooxygenase.
    Roberts MS; Cossum PA; Kilpatrick D
    N Engl J Med; 1985 May; 312(21):1388-9. PubMed ID: 3921841
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase.
    Crook D; Collins AJ
    Ann Rheum Dis; 1977 Oct; 36(5):459-63. PubMed ID: 411427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity.
    Ali M; McDonald JW
    Prostaglandins Med; 1979 Dec; 3(6):327-32. PubMed ID: 121613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin.
    Ali M; McDonald JW; Thiessen JJ; Coates PE
    Stroke; 1980; 11(1):9-13. PubMed ID: 7355437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between platelet cyclooxygenase pathway and plasma malondialdehyde-like material.
    Violi F; Ghiselli A; Alessandri C; Iuliano L; Cordova C; Balsano F
    Lipids; 1985 May; 20(5):322-4. PubMed ID: 3925272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoperoxides and cyclooxygenase activity in thrombocytes in relation to the age of healthy subjects and drugs affecting prostaglandin biosynthesis (Acylpyrin, Indren, Erevit forte)].
    Prikryl P; Rysánek K; Továrek J; Vojtková J; Prikrylová I
    Cas Lek Cesk; 1980 May; 119(22):621-6. PubMed ID: 6775810
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin resistance transient laboratory finding or important clinical entity?
    Lev EI
    J Am Coll Cardiol; 2009 Feb; 53(8):678-80. PubMed ID: 19232900
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
    Pedersen AK; FitzGerald GA
    N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin is a selective inhibitor of platelet cyclooxygenase activity in healthy subjects.
    Patrignani P; Filabozzi P; Patrono C
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():259-64. PubMed ID: 6221533
    [No Abstract]   [Full Text] [Related]  

  • 19. A method for measurement of platelet regeneration in man.
    Hamberg M; Svensson J; Blombäck M
    Prostaglandins Med; 1978 Dec; 1(6):455-60. PubMed ID: 104315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible acylation and inhibition of aggregation of platelets by substituted maleic anhydrides.
    Walder JA; Hyman BT; Heller MJ; Shishido RY; Klotz IM
    Mol Pharmacol; 1977 May; 13(3):407-14. PubMed ID: 406514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.